As of 2025-05-17, the Fair Value of Mersana Therapeutics Inc (MRSN) is -2.78 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.34 USD, the upside of Mersana Therapeutics Inc is -916.20%.
With the market price of 0.34 USD and our fair value calculation, Mersana Therapeutics Inc (MRSN) is not a good investment. Investing in MRSN stocks now will result in a potential loss of 916.20%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -88.05 | -170.06 | -204.21 | -171.67 | -69.19 | -140.64 |
| YoY growth | -212.12% | -93.14% | -20.08% | 15.93% | 59.69% | -49.94% |
| Market Cap (mil) | 42.39 |
| P/E | |
| Forward P/E |
| EPS | -0.56 |
| Avg earnings growth rate | -49.94% |
| TTM earnings | -69.19 |